Close Menu
Gulf Newsbreak
    What's Hot

    Wall Street rises after Treasury expands debt buybacks

    August 20, 2026

    Caldwell Strengthens Life Sciences and Healthcare Practice with Addition of Olga Kozlova in Dubai

    August 19, 2026

    WHO maps three-month path for Congo Ebola containment

    August 19, 2026
    • Home
    • Contact Us
    Facebook X (Twitter) Instagram
    Gulf NewsbreakGulf Newsbreak
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • More
      • Sports
      • Technology
      • Travel
    Gulf Newsbreak
    Home » ZeptoMetrix Launches PROtrol: Quality Control Material for the Lateral Flow Immunoassay Market
    Featured News

    ZeptoMetrix Launches PROtrol: Quality Control Material for the Lateral Flow Immunoassay Market

    May 18, 2023
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email Tumblr Reddit VKontakte Telegram

    BUFFALO, NY / ACCESSWIRE / May 16, 2023 / ZeptoMetrix® is excited to introduce PROtrol TM, a new line of products designed for antigen-based diagnostic methods. These third-party materials mimic a true clinical specimen and can be used to evaluate and monitor the performance of antigen-based assays, including lateral flow immunoassays for infectious diseases.

    ZeptoMetrix logo
    ZeptoMetrix logo

    PROtrol is the only whole organism reference material to provide complete testing data. Each lot of product is supplied with the protein concentration and TCID50 value, which minimizes qualification testing. PROtrol provides better reproducibility, which optimizes the use of financial spending and processing time through the decreased need for repeat testing.

    “The rapid expansion in development of antigen-based assays has highlighted some quality challenges. Inactivated, whole organism controls designed specifically for antigen tests can equip manufacturers with the tools they need to better evaluate the performance of their assays, leading to higher quality tests on the market,” said Dr. Karuna Sharma, Vice President & Chief Scientific Officer.

    PROtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Isolate: USA-WA1/2020* is the first member of this product line (PROSARS(COV2)-587). As we move beyond the COVID-19 pandemic, ZeptoMetrix will continue to grow the PROtrol product line, providing high-quality controls to assay manufacturers seeking to expand access to inexpensive and easy-to-use diagnostics.

    “The launch and expansion of PROtrol enhances our position as the partner of choice for diagnostic test developers,” said Evangeline Gonzalez, President of Antylia Diagnostics division. “As we work with our diagnostic partners, ZeptoMetrix is pleased with the role that PROtrol plays to give patients around the world more access to diagnostic testing.”

    More information on how to order the new PROtrol and additional ZeptoMetrix products can be found at: https://www.zeptometrix.com

    About ZeptoMetrix®
    ZeptoMetrix® is an established industry leader in the design, development, and delivery of innovative, quality solutions to the infectious disease diagnostics market. Our expertise and abilities in molecular diagnostics, including external quality controls, verification panels, proficiency panels, customized and OEM products/services have set the industry standard for performance and reliability and make ZeptoMetrix the preferred choice for independent third-party quality control materials.

    Links:
    * (PROSARS(COV2)-587): product page
    https://www.zeptometrix.com/products/protrolt-sars-cov-2-isolate-usa-wa1-2020-1-ml

    Contact Information

    Andrew Zenger
    Global Product Manager
    andrew.zenger@antylia.com
    (716) 715-7417

    Related Files

    PROSARS(COV2)-587 Product Insert.pdf
    ZeptoMetrix Launches PROtrol.pdf

    SOURCE: ZeptoMetrix

    .

    ZeptoMetrix Launches PROtrol: Quality Control Material for the Lateral Flow Immunoassay Market

    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email

    Related Posts

    Thumbay International Pathway – MD Program, With Installments and a Direct Route to Residency in Romania

    August 21, 2026

    Thumbay Group and UMFST G.E. Palade Targu Mures, Romania Launch Thumbay – UMFST International Residency Pathway Program, Opening the Door to 49 European Medical Specialties

    August 18, 2026

    Papa Johns teams up with Disney and Pixar for Toy Story 5

    August 7, 2026

    Extreme heat wave triggers emergency alerts across Daegu

    July 27, 2026

    Excellence in Dental Education: Gulf Medical University’s College of Dentistry Sets the Clinical Benchmark with 120 Dental Chairs and a Dedicated Teaching Hospital

    July 25, 2026

    XERF arrives in Dubai as Biolite Clinic leads Middle East launch

    July 23, 2026
    Latest News

    Wall Street rises after Treasury expands debt buybacks

    August 20, 2026

    NEW YORK / RankWire.AI / – U.S. stocks ended modestly higher Wednesday as long-term Treasury…

    WHO maps three-month path for Congo Ebola containment

    August 19, 2026

    Indonesia 6.1 earthquake rattles North Sumatra coast

    August 19, 2026

    DRC malaria cases surpass 26 million in 2025

    August 17, 2026

    DRC Ebola outbreak sets national death toll record

    August 17, 2026
    Business

    Wall Street rises after Treasury expands debt buybacks

    August 20, 2026

    South Korea auto exports reach $6.24 billion in July

    August 14, 2026

    Diesel prices rise as US and Europe fuel supplies tighten

    August 12, 2026
    News

    Indonesia 6.1 earthquake rattles North Sumatra coast

    August 19, 2026

    DRC Ebola outbreak sets national death toll record

    August 17, 2026

    Total solar eclipse crosses Russian Arctic and Europe

    August 13, 2026
    Travel

    Etihad sets December start for Abu Dhabi Gothenburg flights

    August 13, 2026

    Spain begins temporary border checks for Italy arrivals

    August 10, 2026

    South Korea tourism surplus reaches post-pandemic high

    August 10, 2026
    © 2026 Gulf Newsbreak | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.